Here are the editors' top picks for the week ended March 22.
Hospital, doctor visits decline as vaccines perform better in '18-'19 flu season
Flu vaccines' effectiveness rates have implications for both healthcare providers and flu shot manufacturers, as shots that offer greater protection from the virus can mean less revenue for hospitals and more sales for vaccine-makers.
Chinese Ebola vaccine maker to IPO in Hong Kong
The CEO of Tianjin-based vaccine maker CanSino Biologics Inc. is betting his company can close the gap on vaccine manufacturing in China, where scandals in recent years have roiled the industry and created a crisis of confidence in the public sphere.
Biogen shares drop over 29% after Alzheimer's trial halt with Eisai
Analysts predicted that shares of Biogen Inc. could slide significantly today as the company's other pipeline prospects are few and commercial products face low growth potential.
New Hampshire's Medicaid work rules challenged in federal court
New Hampshire's Medicaid work requirements are being challenged in the U.S. District Court for the District of Columbia, making New Hampshire the third state facing a lawsuit for pursuing the controversial policy.
Of Mice Not Men: Promising sepsis remedy; lack of sleep linked to heart problems
Research into an experimental therapy for sepsis has shown that a drug being developed at the Royal College of Surgeons in Ireland has the potential to stop sepsis-causing bacteria from triggering organ damage.
Fentanyl overdose deaths spike in men, minorities; group seeks opioid moratorium
Overdose deaths from fentanyl have spiked in men, particularly in African-Americans and Hispanics, U.S. health officials reported. Meanwhile, a consumer watchdog called for a moratorium on the approval of new opioids in the midst of the epidemic.
Gottlieb confident US FDA being left in good shape, but regrets unfinished work
Departing U.S. Food and Drug Administration Commissioner Scott Gottlieb said he was confident he is leaving the agency in good shape, though he acknowledged some work he had hoped to tackle will be left unfinished.
Medicare adviser recommends 2.8% payment rate increase for acute care hospitals
In their March reports to Congress, a Medicare adviser recommends a 2.8% increase in acute care hospital payments and its counterpart for Medicaid recommends slowing down billions of dollars of long-delayed hospital cuts.
Cardiology Roundup: Apple's Watch heart study, Amarin's Vascepa follow-up
The American College of Cardiology meeting brought together more than 16,600 attendees, highlighting clinical trial results, cardiovascular device studies and large outcomes data from hundreds of thousands of patients.
Capitol Checkup: More drug pricing rounds; emerging diseases a perpetual threat
There was more activity on Capitol Hill last week aimed at lowering Americans' costs for prescription medicines; meanwhile, top health officials updated Capitol Hill on the U.S. response to the Ebola outbreak in the Democratic Republic of the Congo.